NCT04189653

Brief Summary

In 2018, continuous monitoring (CM) of 5 vital signs with a wearable device, including automated MEWS calculation within the EMR were introduced on the surgical and internal medicine ward of our hospital. Rather than taking the measurements manually, this enabled the nurses to periodically validate the continuously derived vital signs at the protocolled moments, and simultaneously get an automatically calculated MEWS reading,. Moreover, continuous vital sign monitoring provides single channel alarms and trends of the vital signs in between the regular measurement moments. Compared to periodic manual measurements and registration in the EMR, the continuous vital sign monitoring and automated MEWS calculations in the EMR may result in better identification of clinical deterioration, and may improve clinical outcome. The primary objective of this study is to evaluate changes in total hospital and ward stay, "Total Events" during admission (rapid response team (RRT) calls and unexpected intensive care unit (uICU) admissions and deaths) after implementation of CM on the regular surgical and internal medicine wards. Secondary objective is to evaluate changes in MEWS scores at the moment of the uICU admissions, length of hospital, ward and ICU stay and the proportion of RRT calls that results in a ICU admission.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,896

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 6, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

September 7, 2022

Status Verified

November 1, 2019

Enrollment Period

1 year

First QC Date

December 4, 2019

Last Update Submit

September 6, 2022

Conditions

Keywords

Early Warning ScoresContinuous Vital Sign MonitoringEscalation of CareICU-TransferDeterioration prevention

Outcome Measures

Primary Outcomes (2)

  • Unexpected Intensive Care Unit Admissions

    Unexpected Intensive Care Unit Admissions

    During ward admission, from moment of arival on ward till discharge or transfer, average of 4 days.

  • Rapid Response Team Activations

    Rapid Response Team Activations

    During ward admission, from moment of arival on ward till discharge or transfer, average of 4 days.

Secondary Outcomes (1)

  • Length of Stay

    During ward, ICU and hospital admission, till discharge, transfer to other hospital or death. Average of 5 days.

Study Arms (2)

General Ward Inpatients 2017-2018

ALL General Ward Inpatients on our Gastro-Enterology Surgery ward and Internal Medicine ward in the period august 1st 2017-august 31st 2018.

General Ward Inpatients 2018-2019

ALL General Ward Inpatients on our Gastro-Enterology Surgery ward and Internal Medicine ward in the period august 1st 2018-august 31st 2019.

Other: Continuous Monitoring

Interventions

Wireless continuous vital sign monitoring (HR, RR, SBP/DBP, SAT)

General Ward Inpatients 2018-2019

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult general ward patients of the GE-surgery and Internal Medicine wards of a Dutch tertiary academic hospital.

You may not qualify if:

  • Opt out of file study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboudumc

Nijmegen, Gelderland, 6525GA, Netherlands

Location

MeSH Terms

Conditions

Clinical Deterioration

Interventions

Continuous Glucose Monitoring

Condition Hierarchy (Ancestors)

Disease ProgressionDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineMonitoring, PhysiologicInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2019

First Posted

December 6, 2019

Study Start

August 1, 2018

Primary Completion

August 1, 2019

Study Completion

August 1, 2020

Last Updated

September 7, 2022

Record last verified: 2019-11

Locations